Elligo Health Research announced a partnership with Consortia Health. The partnership, which recently commenced patient enrollment for its first study, extends Elligo’s ability to bridge clinical research and clinical health care to accelerate the development of new products and therapies for the pharmaceutical, biotechnology and medical device industries.
This partnership will leverage Elligo’s Goes Direct capabilities, which utilize electronic health records and other health data to identify patients and physicians for participation in clinical research studies. Elligo will make its offerings available to Consortia’s network of women’s health provider partners including OB-GYN and urology clinics. Working with these clinics, Elligo will provide on-demand clinical research services, technology, infrastructure, processes and on-site personnel to enable the clinics to easily participate in research without incurring costs of their own.
“As our industry knows, strong recruitment is a leading driver of successful clinical trials,” John Potthoff, CEO of Elligo said. “Our goal has been to update the model of clinical trial efficiency by, first, enabling patients to participate while remaining under the care of their own trusted physician, and, second, allowing physicians to conduct trials without the need to incur research infrastructure or personnel costs. The Elligo model has consistently boosted our physician partners’ success through our team’s deep experience in clinical research, attention to detail and focus on patient safety and quality.”